College of Chemistry, Chemical Engineering and Environment, Qingdao University, China.
Clin Chim Acta. 2011 May 12;412(11-12):940-5. doi: 10.1016/j.cca.2011.01.025. Epub 2011 Jan 26.
Diabetic retinopathy (DR), a kind of diabetic microvascular complication, is the leading cause of visual impairment in adults aged 30 to 65 years. Despite rapid research progress, robust predictors to assess prospectively with high precision the risk for DR in individuals with diabetes are still lacking. We investigated the relationship between pyrimidine metabolites and disease, and find out the potential biomarkers for diagnosis.
The study group consisted of 116 subjects who were divided to 3 groups: control (n=41), type 2 diabetes without retinopathy (DM, n=37), and with retinopathy (DR, n=38). Biochemical and clinical parameters, concentrations of related metabolites, including of cytosine, cytidine, uridine, thymine, thymidine and 2'-deoxyuridine were measured in plasma of all participants.
There was a significant increase of concentrations of cytosine (p=0.010), cytidine (p<0.001) and thynidine (p<0.001) with DR compared to DM. The concentration of uridine, thymine and 2'-deoxyuridine did not change.
The concentrations of cytosine, cytidine and thynidine may be useful for monitoring the progression of DR and evaluating the treatment. And cytidine has good sensitivity and specificity for diagnosis.
糖尿病视网膜病变(DR)是一种糖尿病微血管并发症,是 30 至 65 岁成年人视力损害的主要原因。尽管研究进展迅速,但仍缺乏能够准确预测个体糖尿病患者 DR 风险的强大预测因子。我们研究了嘧啶代谢物与疾病的关系,并发现了用于诊断的潜在生物标志物。
研究组包括 116 名受试者,他们被分为 3 组:对照组(n=41)、无视网膜病变的 2 型糖尿病(DM,n=37)和有视网膜病变的 2 型糖尿病(DR,n=38)。所有参与者的血浆中均测量了生化和临床参数以及相关代谢物的浓度,包括胞嘧啶、胞苷、尿嘧啶、胸腺嘧啶、胸苷和 2'-脱氧尿苷。
与 DM 相比,DR 组的胞嘧啶(p=0.010)、胞苷(p<0.001)和胸苷(p<0.001)浓度显著升高。尿嘧啶、胸腺嘧啶和 2'-脱氧尿苷的浓度没有变化。
胞嘧啶、胞苷和胸苷的浓度可能有助于监测 DR 的进展并评估治疗效果。胞苷对诊断具有良好的敏感性和特异性。